Lumida
/AVD
⌘K
American Vanguard Corp

American Vanguard Corp

AVD
$2.17USD↓-5.65%-0.13 today

MARKET CAP

64.0M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$2 – $2

52W RANGE

$2
$6

AI Summary

Stalk
TrimMedium

AVD remains in an early Stage 1 consolidation after a steep decline, with intermediate resistance forming at flattening EMAs and a declining 200 DMA. Medium-term bias stays bearish on the lower-high structure, while short-term timing is neutral. Defer selling into the $2.90–3.00 zone on rejections at the 9/20 EMA or 50 SMA. A decisive break below the EMA zone would trigger accelerated bearish risk and invalidate the current setup.

  • ↑Earnings yield ~19% and book-to-price 1.54 indicate undervaluation.
  • ↑Revisions trending positive; analysts expect $0.09 EPS rebound from -$0.14.
  • ↓Last quarter EPS -$0.14 underscores persistent losses.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

American Vanguard Corporation (NASDAQ: AVD) is a leading manufacturer of agricultural chemicals and fertilizers, specializing in crop protection and soil enhancement products. The company is strategically positioned within the agricultural sector, which is primarily driven by the ongoing demand for efficient agricultural practices amid growing global food demands. As a major player in providing solutions across the value chain of agricultural production, AVD is also focused on transitioning towards sustainable and environmentally friendly farming practices.

Bull says

  • ↑Earnings yield ~19% and book-to-price 1.54 indicate undervaluation.
  • ↑Revisions trending positive; analysts expect $0.09 EPS rebound from -$0.14.
  • ↑CEO bought shares at $2.36, signaling management confidence.
  • ↑Leverage ratio 0.61 implies manageable debt and stable cash flow.
  • ↑Critical support tested; oversold setup may spark short-term bounce.
  • ↑Q2 earnings on Aug 10 could catalyze stock rebound.

Bear says

  • ↓Last quarter EPS -$0.14 underscores persistent losses.
  • ↓Stock down 7.3% recently; momentum remains negative.
  • ↓High short interest and poor liquidity intensify downside pressure.
  • ↓Average analyst rating 'Sell' reflects low market confidence.
  • ↓Sensitivity to oil prices and interest rates adds volatility.
  • ↓Market cap $73.9M limits competitive scale in ag sector.

Earnings Call · Q4 2023 · Mgmt. Guidance

Updated 03-18-2025neutral

Transcript signals

Bull points

  • we are still targeting 2024 net sales to increase by 8% to 12% over 2023.
  • We did get some approvals from EPA for this season that we were looking for.
  • We think we've got some potential pickup value on zinc.

Bear points

  • Due to global destocking activity, a glut of generic products from China and supply issues of two of our leading products, Aztec and Dacthal, our performance for the first nine months of 2023 was below expectations.
  • Some of our competitors have softened their guidance for '24, noting an inventory overhang of their products in the distribution channel. The state of oversupply largely affects South America, particularly Brazil and Europe.
  • The reason we mentioned the 2.75 target is this amendment stays in place for a year and has kind of graduated back to normal to 3.5x.
Read full transcript analysis ›